Articles producció científica> Medicina i Cirurgia

Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis

  • Dades identificatives

    Identificador: imarina:9093099
    Autors:
    Companys, JuditPla-Paga, LauraCalderon-Perez, LorenaLlaurado, ElisabetSola, RosaPedret, AnnaValls, Rosa M.
    Resum:
    Fermented dairy foods (FDFs) and probiotics are promising tools for the prevention and management of cardiometabolic diseases (CMDs), respectively. The relation between the regular consumption of FDFs and CMD risk factors was assessed by prospective cohort studies (PCSs), and the effect of probiotic supplementation added into a dairy matrix on CMD parameters was evaluated by randomized controlled trials (RCTs). Moreover, the effects of probiotic supplementation added into a dairy matrix were compared with those administered in capsule/powder form. Twenty PCSs and 52 RCTs met the inclusion criteria for the systematic review and meta-analysis. In PCSs, fermented milk was associated with a 4% reduction in risk of stroke, ischemic heart disease, and cardiovascular mortality [RR (95% CI); 0.96 (0.94, 0.98)]; yogurt intake was associated with a risk reduction of 27% [RR (95% CI); 0.73 (0.70, 0.76)] for type 2 diabetes (T2D) and 20% [RR (95% CI); 0.80 (0.74, 0.87)] for metabolic syndrome development. In RCTs, probiotic supplementation added into dairy matrices produced a greater reduction in lipid biomarkers than when added into capsules/powder in hypercholesterolemic subjects, and probiotic supplementation by capsules/powder produced a greater reduction in T2D biomarkers than when added into dairy matrices in diabetic subjects. Both treatments (dairy matrix and capsules/powder) resulted in a significant reduction in anthropometric parameters in obese subjects. In summary, fermented milk consumption is associated with reduced cardiovascular risk, while yogurt intake is associated with a reduced risk of T2D and metabolic syndrome development in the general population. Furthermore, probiotic supplementation added into dairy matrices could be considered beneficial for lowering li
  • Altres:

    Autor segons l'article: Companys, Judit; Pla-Paga, Laura; Calderon-Perez, Lorena; Llaurado, Elisabet; Sola, Rosa; Pedret, Anna; Valls, Rosa M.;
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Calderon Pérez, Lorena / Companys Alemany, Judit / Llauradó Ribé, Elisabet / Pedret Figuerola, Anna / PLA PAGA, LAURA / Solà Alberich, Rosa Maria / Valls Zamora, Rosa Maria
    Paraules clau: Yogurt consumption Visceral fat accumulation Type-2 diabetes-mellitus Type 2 diabetes Probiotics Obesity Metabolic syndrome Lipid profile Lactobacillus-gasseri sbt2055 Hypercholesterolemia Glycemic control Fermented dairy Double-blind Cardiometabolic disease Body-mass index Blood mononuclear-cells
    Resum: Fermented dairy foods (FDFs) and probiotics are promising tools for the prevention and management of cardiometabolic diseases (CMDs), respectively. The relation between the regular consumption of FDFs and CMD risk factors was assessed by prospective cohort studies (PCSs), and the effect of probiotic supplementation added into a dairy matrix on CMD parameters was evaluated by randomized controlled trials (RCTs). Moreover, the effects of probiotic supplementation added into a dairy matrix were compared with those administered in capsule/powder form. Twenty PCSs and 52 RCTs met the inclusion criteria for the systematic review and meta-analysis. In PCSs, fermented milk was associated with a 4% reduction in risk of stroke, ischemic heart disease, and cardiovascular mortality [RR (95% CI); 0.96 (0.94, 0.98)]; yogurt intake was associated with a risk reduction of 27% [RR (95% CI); 0.73 (0.70, 0.76)] for type 2 diabetes (T2D) and 20% [RR (95% CI); 0.80 (0.74, 0.87)] for metabolic syndrome development. In RCTs, probiotic supplementation added into dairy matrices produced a greater reduction in lipid biomarkers than when added into capsules/powder in hypercholesterolemic subjects, and probiotic supplementation by capsules/powder produced a greater reduction in T2D biomarkers than when added into dairy matrices in diabetic subjects. Both treatments (dairy matrix and capsules/powder) resulted in a significant reduction in anthropometric parameters in obese subjects. In summary, fermented milk consumption is associated with reduced cardiovascular risk, while yogurt intake is associated with a reduced risk of T2D and metabolic syndrome development in the general population. Furthermore, probiotic supplementation added into dairy matrices could be considered beneficial for lowering lipid concentrations and reducing anthropometric parameters. Additionally, probiotic capsule/powder supplementation could contribute to T2D management and reduce anthropometric parameters. However, these results should be interpreted with caution due to the heterogeneity of the studies and the different probiotic strains used in the studies.
    Àrees temàtiques: Saúde coletiva Nutrition and dietetics Nutrition & dietetics Nutrição Medicine (miscellaneous) Medicina ii Food science Educação física Ciências biológicas ii Ciências biológicas i Ciência de alimentos
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: lorena.calderon@urv.cat judit.companys@urv.cat anna.pedret@urv.cat elisabet.llaurado@urv.cat rosa.sola@urv.cat rosamaria.valls@urv.cat lorena.calderon@urv.cat judit.companys@urv.cat judit.companys@urv.cat
    Identificador de l'autor: 0000-0003-0766-0733 0000-0003-1485-0818 0000-0002-5327-932X 0000-0002-7439-9531 0000-0002-8359-235X 0000-0002-3351-0942 0000-0003-0766-0733 0000-0003-1485-0818 0000-0003-1485-0818
    Data d'alta del registre: 2024-06-22
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://academic.oup.com/advances/article-abstract/11/4/834/5819130?redirectedFrom=fulltext
    Referència a l'article segons font original: Advances In Nutrition. 11 (4): 834-863
    Referència de l'ítem segons les normes APA: Companys, Judit; Pla-Paga, Laura; Calderon-Perez, Lorena; Llaurado, Elisabet; Sola, Rosa; Pedret, Anna; Valls, Rosa M.; (2020). Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis. Advances In Nutrition, 11(4), 834-863. DOI: 10.1093/advances/nmaa030
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI de l'article: 10.1093/advances/nmaa030
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2020
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Food Science,Medicine (Miscellaneous),Nutrition & Dietetics,Nutrition and Dietetics
    Yogurt consumption
    Visceral fat accumulation
    Type-2 diabetes-mellitus
    Type 2 diabetes
    Probiotics
    Obesity
    Metabolic syndrome
    Lipid profile
    Lactobacillus-gasseri sbt2055
    Hypercholesterolemia
    Glycemic control
    Fermented dairy
    Double-blind
    Cardiometabolic disease
    Body-mass index
    Blood mononuclear-cells
    Saúde coletiva
    Nutrition and dietetics
    Nutrition & dietetics
    Nutrição
    Medicine (miscellaneous)
    Medicina ii
    Food science
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Ciência de alimentos
  • Documents:

  • Cerca a google

    Search to google scholar